Terms & Conditions
Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.
Search results
Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.
Thursday 15 May 2025, 7.00pm - 8.00pm - via Zoom - Come and join us for our latest meeting where we will be joined by our guest speakers and new sponsors, EMVI - A Mobile Visual Assistant Designed by and for the Visually Impaired.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
We provide funding for innovative, high quality research projects investigating the causes and potential treatments for all forms of inherited retinal disease.
Making yourself aware of the what you are entitled to, and understanding the diagnosis pathway for inherited sight loss, will put you in a stronger position to seek better support.
Inside this edition, set yourself a challenge in 2024, plus find out about our brand new lottery.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Researchers have developed PEDF-based eye drops that show promise in slowing retinal degeneration in mice with retinitis pigmentosa, potentially offering a non-invasive treatment option for preserving vision in the future.
An American living with Leber congenital amaurosis 10 (LCA10) has become the first clinical trial participant in the world to receive a CRISPR gene editing treatment in vivo (inside the body).
This session will introduce the technique of optogenetics and its potential for development into a treatment for IRDs.